Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 51, Issue , 2014, Pages 126-132

  Hritcu, Lucian ^a   Gorgan, Lucian Dragos ^a  

^a ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Anxiety; BDNF mRNA expression; Depression; Lipopolysaccharide; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL; ANXIETY; CHEMICALLY INDUCED; DEPRESSION; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; MALE; MAZE TEST; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; RAT; SUBSTANTIA NIGRA; SWIMMING; TOXICITY; WISTAR RAT;

ANIMALS; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANTIA NIGRA; SWIMMING;

EID: 84893950899     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.01.016     Document Type: Article

References (53)

1. Baluchnejadmojarad T., Roghani M., Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-Parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett 2010, 480:206-210.
2. Barrientos R.M., Higgins E.A., Sprunger D.B., Watkins L.R., Rudy J.W., Maier S.F. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res 2002, 134:291-298.
3. Barrientos R.M., Sprunger D.B., Campeau S., Watkins L.R., Rudy J.W., Maier S.F. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J Neuroimmunol 2004, 155:119-126.
4. Barry C.E., Nolan Y., Clarke R.M., Lynch A., Lynch M.A. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J Neurochem 2005, 93:221-231.
5. Bilbo S.D., Barrientos R.M., Eads A.S., Northcutt A., Watkins L.R., Rudy J.W., et al. Early-life infection leads to altered BDNF and IL-1β mRNA expression in rat hippocampus following learning in adulthood. Brain Behav Immun 2008, 22:451-455.
6. Campos M., Fernandes E., Ferreira J., Santos A.S., Calixto J. Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms. Psychopharmacology (Berl) 2005, 182:45-53.
7. Castilla-Ortega E., Escuredo L., Bilbao A., Pedraza C., Orio L., Estivill-Torrús G., et al. 1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats. PLoS One 2014, 9:e85348.
8. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260-265.
9. Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi C., Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 2012, 39:112-119.
10. Cowansage K., LeDoux J., Monfils M. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 2010, 3:12-29.
11. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
12. Dunham J., Deakin J., Miyajima F., Payton A., Tor C. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 2009, 43:1175-1184.
13. Durant C., Christmas D., Nutt D. The pharmacology of anxiety. Curr Top Behav Neurosci 2010, 2:303-330.
14. Ferreira Mello B.S., Monte A.S., McIntyre R.S., Soczynska J.K., Custódio C.S., Cordeiro R.C., et al. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 2013, 47:1521-1529.
15. Figurov A., Pozzo-Miller L., Olafsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996, 381:706-709.
16. Franklin J.M., Carrasco G.A., Moskovitz J. Induction of methionine sulfoxide reductase activity by pergolide, pergolide sulfoxide, and S-adenosyl-methionine in neuronal cells. Neurosci Lett 2013, 533:86-89.
17. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
18. Fuller R., Clemens J. Pergolide: a dopamine agonist at both D1 and D2 receptors. Life Sci 1991, 49:925-930.
19. Fumagalli F., Racagni G., Riva M.A. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J 2006, 6:95-104.
20. Grønli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., et al. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 2006, 85:842-849.
21. Grundmann O., Nakajima J.-I., Seo S., Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 2007, 110:406-11.
22. Guan Z., Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun 2006, 20:64-71.
23. Gubba E.M., Fawcett J.W., Herbert J. The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. Brain Res Mol Brain Res 2004, 127:48-59.
24. Hayashi Y., Sogabe S., Hattori Y., Tanaka J. Anxiolytic and hypnotic effects in mice of roasted coffee bean volatile compounds. Neurosci Lett 2012, 531:166-169.
25. Hennigan A., Trotter C., Kelly Á.M. Lipopolysaccharide impairs long-term potentiation and recognition memory and increases p75NTR expression in the rat dentate gyrus. Brain Res 2007, 1130:158-166.
26. Herrera-Marschitz M., Arbuthnott G., Ungerstedt U. The rotational model and microdialysis: significance for dopamine signalling, clinical studies, and beyond. Prog Neurobiol 2010, 90:176-189.
27. Hritcu L., Ciobica A. Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: relevance for Parkinson's disease. Behav Brain Res 2013, 253:25-31.
28. Hritcu L., Ciobica A., Stefan M., Mihasan M., Palamiuc L., Nabeshima T. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease. Neurosci Res 2011, 71:35-43.
29. Kano O., Ikeda K., Cridebring D., Takazawa T., Yoshii Y., Iwasaki Y. Neurobiology of depression and anxiety in Parkinson's disease. Park Dis 2011, 2011.
30. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysacchride-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000, 20:6309-6316.
31. Kinoshita S., Yasuda H., Taniguchi N., Katoh-Semba R., Hatanaka H., Tsumoto T. Brain-derived neurotrophic factor prevents low-frequency inputs from inducing long-term depression in the developing visual cortex. J Neurosci 1999, 19:2122-2130.
32. Kruse N., Cetin S., Chan A., Gold R., Lühder F. Differential expression of BDNF mRNA splice variants in mouse brain and immune cells. J Neuroimmunol 2007, 182:13-21.
33. Kunugi H., Hori H., Adachi N., Numakawa T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 2010, 64:447-459.
34. Lapchak P.A., Araujo D.M., Hefti F. Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 1993, 53:297-301.
35. Lin Y.-L., Lin S.-Y., Wang S. Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stress-induced corticosterone responses in adult rats. Brain Behav Immun 2012, 26:459-468.
36. Liu B., Hong J.S. Role of microglia in inflammation mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003, 304:1-7.
37. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(DDC(T)) method. Methods 2001, 25:402-408.
38. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007, 10:1089-1093.
39. Matthews S.C., Paulus M.P., Dimsdale J.E. Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C. Psychosomatics 2004, 45:281-286.
40. Monje M., Toda H., Palmer T. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
41. Musumeci G., Minichiello L. BDNF-TrkB signalling in fear learning: from genetics to neural networks. Rev Neurosci 2011, 22:303-315.
42. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, London. 6th ed.
43. Peng C.-H., Chiou S.-H., Chen S.-J., Chou Y.-C., Ku H.-H., Cheng C.-K., et al. Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 2008, 18:128-140.
44. Quesseveur G., David D.J., Gaillard M.C., Pla P., Wu M.V., Nguyen H.T., et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl Psychiatry 2013, 3:e253.
45. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 1997, 21:801-810.
46. Sriraksa N., Wattanathorn J., Muchimapura S., Tiamkao S., Brown K., Chaisiwamongkol K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-Hydroxydopamine. Evid Based Complement Alternat Med 2012, Volume 2012. Article ID 823206, 9 pages.
47. Swiergiel A.H., Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 2007, 86:651-659.
48. Tolardo R., Zetterman L., Bitencourtt D.R., Mora T.C., de Oliveira F.L., Biavatti M.W., et al. Evaluation of behavioral and pharmacological effects of Hedyosmum brasiliense and isolated sesquiterpene lactones in rodents. J Ethnopharmacol 2010, 128:63-70.
49. Tong L., Balazs R., Soiampornkul R., Thangnipon W., Cotman C.W. Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 2008, 29:1380-1393.
50. Vereker E., Campbell V., Roche E., McEntee E., Lynch M.A. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 2000, 275:26252-26258.
51. Wang Y., Zhang T.-Y., Xin J., Li T., Yu H., Li N., et al. Differential involvement of brain-derived neurotrophic factor in reconsolidation and consolidation of conditioned taste aversion memory. PLoS One 2012, 7:e49942.
52. Yu H., Chen Z.-y. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 2011, 32:3-11.
53. Yu H., Wang Y., Pattwell S., Jing D., Liu T., Zhang Y., et al. Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci 2009, 29:4056-4064.